0001209191-23-003177.txt : 20230112
0001209191-23-003177.hdr.sgml : 20230112
20230112171110
ACCESSION NUMBER: 0001209191-23-003177
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230111
FILED AS OF DATE: 20230112
DATE AS OF CHANGE: 20230112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HULME ALLISON
CENTRAL INDEX KEY: 0001573886
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40928
FILM NUMBER: 23526561
MAIL ADDRESS:
STREET 1: C/O SOPHIRIS BIO INC., 1258 PROSPECT ST
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ventyx Biosciences, Inc.
CENTRAL INDEX KEY: 0001851194
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 832996852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 662 ENCINITAS BLVD., STE. 250
CITY: ENCINITAS
STATE: CA
ZIP: 92024
BUSINESS PHONE: (858) 945-2393
MAIL ADDRESS:
STREET 1: 662 ENCINITAS BLVD., STE. 250
CITY: ENCINITAS
STATE: CA
ZIP: 92024
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-11
0
0001851194
Ventyx Biosciences, Inc.
VTYX
0001573886
HULME ALLISON
C/O VENTYX BIOSCIENCES, INC.
662 ENCINITAS BLVD, SUITE 250
ENCINITAS
CA
92024
1
0
0
0
Stock Option (right to buy)
34.16
2023-01-11
4
A
0
12880
0.00
A
2033-01-11
Common Stock
12880
12880
D
One-thirty sixth (1/36th) of the Shares subject to the option will be scheduled to vest each month following the grant date, in each case subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2021 Equity Incentive Plan) through the applicable vesting date.
/s/ Christopher Krueger, as Attorney-in-Fact
2023-01-12